Jason Gorevic, CEO of TelaDoc, adds, "This investment signals strong market confidence in TelaDoc and its ability to remove barriers to patient care, which is an important component in all versions of health care reform. We are very excited to add HLM and Cardinal to our team, and we appreciate Trident Capital's continued support of the Company. We look forward to leveraging our investors' strategic relationships, insight and expertise to help TelaDoc achieve its full potential. Our investors understand that TelaDoc's solution means efficiency and cost-effectiveness.